Cargando…
Driver Mutations in Leukemia Promote Disease Pathogenesis through a Combination of Cell-Autonomous and Niche Modulation
Studies of patients with acute myeloid leukemia (AML) have led to the identification of mutations that affect different cellular pathways. Some of these have been classified as preleukemic, and a stepwise evolution program whereby cells acquire additional mutations has been proposed in the developme...
Autores principales: | Ramdas, Baskar, Mali, Raghuveer Singh, Palam, Lakshmi Reddy, Pandey, Ruchi, Cai, Zhigang, Pasupuleti, Santhosh Kumar, Burns, Sarah S., Kapur, Reuben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363747/ https://www.ncbi.nlm.nih.gov/pubmed/32502465 http://dx.doi.org/10.1016/j.stemcr.2020.05.002 |
Ejemplares similares
-
Combined heterozygosity of FLT3(ITD), TET2, and DNMT3A results in aggressive leukemia
por: Ramdas, Baskar, et al.
Publicado: (2022) -
Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway
por: Palam, Lakshmi Reddy, et al.
Publicado: (2023) -
Role of intracellular tyrosines in activating KIT induced myeloproliferative disease
por: Ma, Peilin, et al.
Publicado: (2012) -
Targeting Rho Associated Kinases in Leukemia and Myeloproliferative Neoplasms
por: Mali, Raghuveer Singh, et al.
Publicado: (2012) -
Inhibition of BTK and PI3Kδ impairs the development of human JMML stem and progenitor cells
por: Ramdas, Baskar, et al.
Publicado: (2022)